Home › Compare › KHRWF vs VYM

KHRWF vs VYM: Dividend Comparison 2026

KHRWF yields 13333.33% · VYM yields 2.37%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KHRWF wins by $944051876715324800.00M in total portfolio value
10 years
KHRWF
KHRWF
● Live price
13333.33%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$944051876715324800.00M
Annual income
$930,326,183,604,330,300,000,000.00
Full KHRWF calculator →
VYM
Vanguard High Dividend Yield ETF
● Live price
2.37%
Share price
$148.10
Annual div
$3.51
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.8K
Annual income
$272.94
Full VYM calculator →

Portfolio growth — KHRWF vs VYM

📍 KHRWF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKHRWFVYM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KHRWF + VYM cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
KHRWF pays
VYM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KHRWF
Annual income on $10K today (after 15% tax)
$1,133,333.33/yr
After 10yr DRIP, annual income (after tax)
$790,777,256,063,680,700,000,000.00/yr
VYM
Annual income on $10K today (after 15% tax)
$201.60/yr
After 10yr DRIP, annual income (after tax)
$232.00/yr
At 15% tax rate, KHRWF beats the other by $790,777,256,063,680,700,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KHRWF + VYM for your $10,000?

KHRWF: 50%VYM: 50%
100% VYM50/50100% KHRWF
Portfolio after 10yr
$472025938357662400.00M
Annual income
$465,163,091,802,165,140,000,000.00/yr
Blended yield
98.55%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KHRWF buys
0
VYM buys
0
No recent congressional trades found for KHRWF or VYM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKHRWFVYM
Forward yield13333.33% ✓2.37%
Annual dividend / share$2.00$3.51 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$944051876715324800.00M ✓$27.8K
Annual income after 10y$930,326,183,604,330,300,000,000.00 ✓$272.94
Total dividends collected$943142383073684224.00M ✓$2.6K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: KHRWF vs VYM ($10,000, DRIP)

YearKHRWF PortfolioKHRWF Income/yrVYM PortfolioVYM Income/yrGap
1← crossover$1,344,033$1,333,333.33$11,147$237.17+$1.33M → KHRWF
2$168,918,905$167,480,789.20$12,404$242.33+$168.91M → KHRWF
3$19,852,785,021$19,672,041,793.12$13,780$247.16+$19852.77M → KHRWF
4$2,182,013,981,744$2,160,771,501,770.83$15,285$251.67+$2182013.97M → KHRWF
5$224,287,824,199,531$221,953,069,239,064.90$16,932$255.88+$224287824.18M → KHRWF
6$21,561,870,489,323,890$21,321,882,517,430,390.00$18,733$259.81+$21561870489.31M → KHRWF
7$1,938,749,165,623,537,400$1,915,677,964,199,961,300.00$20,701$263.46+$1938749165623.52M → KHRWF
8$163,055,200,603,353,700,000$160,980,738,996,136,500,000.00$22,852$266.86+$163055200603353.69M → KHRWF
9$12,827,750,571,022,997,000,000$12,653,281,506,377,408,000,000.00$25,201$270.01+$12827750571022998.00M → KHRWF
10$944,051,876,715,324,800,000,000$930,326,183,604,330,300,000,000.00$27,768$272.94+$944051876715324800.00M → KHRWF

KHRWF vs VYM: Complete Analysis 2026

KHRWF — Stock

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Full KHRWF Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →
📬

Get this KHRWF vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KHRWF vs SCHDKHRWF vs JEPIKHRWF vs OKHRWF vs KOKHRWF vs MAINKHRWF vs VIGKHRWF vs DGROKHRWF vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.